Repositorio Digital de la UPF
Publicación
Artículo científico (JournalArticle)
Dietary patterns and lifestyle factors as determinants of body mass index and body composition in individuals with Down Syndrome-A study across three clinical sites
Background/Objectives: It is often reported in the literature that the prevalence of obesity is high in individuals with Down Syndrome (DS). This study aims to assess how lifestyle factors-diet quality, nutrient intake or physical activity-contribute to weight gain. Methods: 230 males/females with DS, aged 12-45 years, were recruited across three geographically independent sites. A total of 185 participants were considered for this analysis and classified into normal-weight, overweight, and obese categories. Diet quality and nutrient intake were calculated using country-specific FFQs. Physical activity was assessed with the Minnesota Leisure Time Activity Questionnaire. Body composition measures were obtained with a bioimpedance scale. Results: The study corroborates a higher prevalence (%) of overweight/obesity in our DS cohort compared to the general population. Higher BMIs were significantly correlated with older age (p < 0.001), lower physical activity (p < 0.05), higher parental BMIs (p < 0.001, mother's BMI; p < 0.05, father's BMI), and increased adiposity indicators. Excess body weight showed an inverse association only with protein intake (p < 0.001). No significant differences emerged in total caloric or other macronutrients intake across BMI categories. However, notable differences in dietary patterns were observed among the three countries, reflecting cultural influences. A smaller exploratory sub-study suggested a potential relationship between higher IQ scores and better diet quality (p < 0.05). Conclusions: These findings provide new insights into contributors to overweight/obesity in DS people, indicating an influence of age, physical activity, familial factors, and body composition. Higher protein intake and culturally adapted lifestyle interventions may contribute to improving weight-related outcomes., The Gene Overdosage and Comorbidities During the Early Lifetime in Down Syndrome (GO-DS21) project has received funding from the European Union's Horizon research and innovation program under grant agreement n- SC1848077. The CIBEROBN is an initiative of the ISCIII. This work was supported by grants from DIUE de la Generalitat de Catalunya (2021SGR00253) and from the Ministerio de Ciencia, Innovanción y Universidades (PID2023-148033OB-C21). LFC received funding from a Medical Research Council UK and Academy of Medical Sciences fellowship grant (G0802796), aWellcome Trust grant (217543/Z/19/Z), BBSRC (BB/W018276/1), and Barts Charity grant (G-002162). AS received funding from the Jerome Lejeune Foundation, and the MRC (grant numbers MR/S011277/1, MR/S005145/1, and MR/R024901/1).
Proyecto:
EC / H2020 848077
,
ES / 3PE PID2023-148033OB-C21